Cognios Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Cognios Capital's GILD Position: Q2 2020 in Review
Cognios Capital sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 7,096 shares — an estimated $530K sold.
Cognios Capital first reported a position in GILD in Q3 2015 and held it in 19 quarters. The position peaked at $12.9M in Q2 2016. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.
- Cognios Capital reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
- Cognios Capital sold 7,096 Gilead Sciences shares in Q2 2020, an estimated $530K.
- Cognios Capital first reported a position in Gilead Sciences in Q3 2015 and held it in 19 quarters.
- Cognios Capital's Gilead Sciences position peaked at $12.9M in Q2 2016.
- 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.
Based on Cognios Capital's 13F filing for Q2 2020.